India to Philippines: Regorafenib Export Trade Route
India has recorded 7 verified shipments of Regorafenib exported to Philippines, representing a combined trade value of $11.6K USD. This corridor is served by 4 active Indian exporters, with an average shipment value of $1.7K USD. The leading Indian exporter is SANSKRUTI PHARMA, which accounts for 93% of total export value with 4 shipments worth $10.9K USD. On the buying side, CLIENT CODE PH001, is the largest importer in Philippines with $6.5K USD in purchases. The top 3 suppliers — SANSKRUTI PHARMA, SANSKRUTI PHARMA , YARAPMIN LIFECARE — together control 99% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Philippines Regorafenib corridor is one of India's established pharmaceutical export routes, with 7 shipments documented worth a combined $11.6K USD. The route is dominated by SANSKRUTI PHARMA, which alone accounts for roughly 93% of all export value, reflecting the consolidated nature of India's regorafenib manufacturing sector.
Across 4 active suppliers, the average shipment value stands at $1.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (65%) and air (15%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during July–September, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 24.2%, placing it at rank #2 among India's top regorafenib export destinations globally.
On the import side, key buyers of Indian regorafenib in Philippines include CLIENT CODE PH001,, CLIENT CODE PH001, CLIENT CODE PH001, and 2 others. CLIENT CODE PH001, is the single largest importer with 2 shipments valued at $6.5K USD.
Route Characteristics
- Average transit34 days
- Peak seasonQ3
- Primary modeMulti-modal
- Top portSAHAR AIR CARGO ACC (INBOM4)
Market Position
- Global rank#2
- Annual growth+24.2%
- Demand growth+20.5%
- Regulatory ease65/100
Top 10 Indian Regorafenib Exporters to Philippines
Showing top 10 of 4 Indian suppliers exporting Regorafenib to Philippines, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SANSKRUTI PHARMA Avg $2.7K per shipment | 4 | $10.9K | 93.4% |
| 2 | SANSKRUTI PHARMA Avg $498 per shipment | 1 | $498 | 4.3% |
| 3 | YARAPMIN LIFECARE Avg $159 per shipment | 1 | $159 | 1.4% |
| 4 | YARAPMIN LIFECARE Avg $112 per shipment | 1 | $112 | 1.0% |
This table shows the top 10 of 4 Indian companies exporting regorafenib to Philippines, ranked by total trade value. The listed exporters are: SANSKRUTI PHARMA, SANSKRUTI PHARMA , YARAPMIN LIFECARE, YARAPMIN LIFECARE . SANSKRUTI PHARMA is the dominant supplier with 4 shipments worth $10.9K USD, giving it a 93% market share. The top 3 suppliers together account for 99% of the total trade value on this route.
Top 10 Regorafenib Importers in Philippines
Showing top 10 of 5 known buyers in Philippines receiving Regorafenib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian regorafenib in Philippines include CLIENT CODE PH001,, CLIENT CODE PH001, CLIENT CODE PH001, , CUSTOMER NUMBER YL 0090, CUSTOMER NUMBER.: YL-0090 . The largest importer is CLIENT CODE PH001,, accounting for $6.5K USD across 2 shipments — representing 56% of all regorafenib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CLIENT CODE PH001, | 2 | $6.5K | 55.9% |
| 2 | CLIENT CODE PH001 | 2 | $4.4K | 37.5% |
| 3 | CLIENT CODE PH001, | 1 | $498 | 4.3% |
| 4 | CUSTOMER NUMBER YL 0090 | 1 | $159 | 1.4% |
| 5 | CUSTOMER NUMBER.: YL-0090 | 1 | $112 | 1.0% |
Top 10 Regorafenib Formulations Imported by Philippines
Showing top 10 of 7 product formulations shipped on the India to Philippines Regorafenib route, ranked by trade value
Philippines imports a wide range of regorafenib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — REGONAT 40MG (REGORAFENIB TABLETS 40MG), — accounts for $4.6K USD across 1 shipments. A total of 7 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | REGONAT 40MG (REGORAFENIB TABLETS 40MG), | 1 | $4.6K | 39.3% |
| 2 | REGONAT 40MG (REGORAFENIB TABLETS 40MG),PACK:BOTTLE | 1 | $2.2K | 19.0% |
| 3 | REGONAT (REGORAFENIB 40MG TABLET), PACK - BOTTLE | 1 | $2.2K | 18.6% |
| 4 | REGONAT 40MG (REGORAFENIB TABLETS 40MG), | 1 | $1.9K | 16.6% |
| 5 | REGONAT(REGORAFENIB 40MG CAPSULE) | 1 | $498 | 4.3% |
| 6 | REGONAT HARMLESS MEDICINE REGORAFENIB 40MG TABLETS | 1 | $159 | 1.4% |
| 7 | HARMLESS MEDICINE REGORAFENIB 40MG TABLE | 1 | $112 | 1.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 65% sea for bulk, 15% air for urgent orders.
Top Ports of Origin
SAHAR AIR CARGO ACC (INBOM4) handles the highest volume with 4 shipments. Transit time averages 34 days by sea.
Market Dynamics
India's regorafenib exports to Philippines are driven primarily by a handful of large-scale manufacturers. SANSKRUTI PHARMA with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SANSKRUTI PHARMA, SANSKRUTI PHARMA , YARAPMIN LIFECARE — together account for 99% of total trade value on this route. The average shipment value of $1.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as regonat 40mg (regorafenib tablets 40mg),pack:bottle and regonat (regorafenib 40mg tablet), pack - bottle, suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, CLIENT CODE PH001, is the largest importer with 2 shipments worth $6.5K USD — representing 56% of all regorafenib imports from India on this route.
Route Statistics
- Trade Volume
- $11.6K
- Avg. Shipment
- $1.7K
- Suppliers
- 4
- Buyers
- 5
- Transit (Sea)
- ~34 days
- Annual Growth
- +24.2%
Related Analysis
Other Regorafenib Routes
Unlock the Full India to Philippines Regorafenib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 7 shipments on this route.
Frequently Asked Questions — India to Philippines Regorafenib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Regorafenib to Philippines?
The leading Indian exporters of Regorafenib to Philippines are SANSKRUTI PHARMA, SANSKRUTI PHARMA , YARAPMIN LIFECARE. SANSKRUTI PHARMA holds the largest market share at approximately 93% of total trade value on this route.
Q What is the total value of Regorafenib exports from India to Philippines?
India exports Regorafenib to Philippines worth approximately $11.6K USD across 7 recorded shipments. The average value per shipment is $1.7K USD.
Q Which ports does India use to ship Regorafenib to Philippines?
The most active port of origin is SAHAR AIR CARGO ACC (INBOM4) with 4 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 65% of shipments going by sea and 15% by air.
Q How long does shipping take from India to Philippines for Regorafenib?
The average transit time for Regorafenib shipments from India to Philippines is approximately 34 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to Philippines Regorafenib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 24.2% with demand growth tracking at 20.5%. The route is ranked #2 among India's top Regorafenib export destinations globally.
Q How many suppliers are active on the India to Philippines Regorafenib route?
There are currently 4 active Indian suppliers exporting Regorafenib to Philippines. The market is moderately concentrated with SANSKRUTI PHARMA accounting for 93% of total shipment value.
Q Who are the main importers of Regorafenib from India in Philippines?
The leading importers of Indian Regorafenib in Philippines include CLIENT CODE PH001,, CLIENT CODE PH001, CLIENT CODE PH001, , CUSTOMER NUMBER YL 0090, CUSTOMER NUMBER.: YL-0090 . CLIENT CODE PH001, is the largest buyer with 2 shipments worth $6.5K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Philippines export trade corridor identified from Indian Customs (DGFT) records for Regorafenib.
- 2.Supplier/Buyer Matching: 4 Indian exporters and 5 importers in Philippines matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 7 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
7 Verified Shipments
4 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists